Crossmark

Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies

Crossref DOI link: https://doi.org/10.1007/s00432-017-2523-2

Published Online: 2017-09-20

Published Print: 2018-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Boglione-Kerrien, C. https://orcid.org/0000-0002-4527-0958
Picard, S.

Tron, C.

Nimubona, S.

Gangneux, J.-P.

Lalanne, S.

Lemaitre, F.

Bellissant, E.

Verdier, M.-C.

Petitcollin, A.
License Information

License valid from 2017-09-20